Staying Ahead of the Curve

We anticipate market opportunities, and implement efficient processes that enable fast decision making.

Priorities & Driving Force

With continued commitment to our core values, Virtus will expand it product portfolio through the execution of its Research and Development strategy. The company has numerous ANDA products in various stages of development.

The company has an aggressive product development pipeline including new drug applications (“NDAs”), 505(b)(2) applications, and abbreviated new drug applications (“ANDAs”) with over a dozen products in various stages of development. Virtus’s product development initiatives are led by its in-house team of drug development experts.

Strategic Initiatives

  • Provide outstanding customer service with a focus on cost saving and profitability.
  • Focus on difficult to manufacture products
  • Introduce multiple new products per quarter
  • Develop and Market high-potential unique products
  • Consistently be first or second to market with products
  • Develop new 505(b)(2), ANDA or 510(k) products
  • In-License Products